Cormedix (CRMD) Receives a Buy From Truist Financial
CorMedix Is Maintained at Buy by Truist Securities
Cormedix Analyst Ratings
JMP Securities Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $19
Cormedix (CRMD) Receives a Buy From JMP Securities
Buy Rating on Cormedix Affirmed Amidst DefenCath's Strong Market Entry and Growth Prospects
JMP Securities Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $19
Rodman & Renshaw Initiates CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13
CorMedix Price Target Announced at $13.00/Share by Rodman & Renshaw
Rodman & Renshaw Initiates Coverage On Cormedix With Buy Rating, Announces Price Target of $13
Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $9 to $19
Cormedix (CRMD) Gets a Buy From Truist Financial
Needham Reiterates Buy on Cormedix, Maintains $10 Price Target
Cormedix Analyst Ratings
CorMedix Price Target Cut to $12.00/Share From $14.00 by Truist Securities
Truist Securities Maintains Buy on Cormedix, Lowers Price Target to $12
Cormedix Analyst Ratings
Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $12
Cormedix Analyst Ratings